Larotrectinib Capsules and Pneumococcal Polysaccharide Vaccine (23-Valent)
Determining the interaction of Larotrectinib Capsules and Pneumococcal Polysaccharide Vaccine (23-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: pneumococcal 23-polyvalent vaccine
Brand name: Pneumovax 23
Synonyms: Pneumococcal polysaccharides vaccine (PPSV), 23-valent
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Capsules-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Larotrectinib Capsules-Pneumovax 23
- Larotrectinib Capsules-PNV - Omega
- Larotrectinib Capsules-PNV Iron Polysaccharides, Folic Acid, DHA
- Larotrectinib Capsules-PNV OB with DHA
- Larotrectinib Capsules-PNV Prenatal plus Multivitamin
- Pneumococcal Polysaccharide Vaccine (23-Valent)-Larotrectinib Oral Solution
- Pneumococcal Polysaccharide Vaccine (23-Valent)-Larotrectinib Sulfate
- Pneumococcal Polysaccharide Vaccine (23-Valent)-Lartruvo
- Pneumococcal Polysaccharide Vaccine (23-Valent)-Larynex
- Pneumococcal Polysaccharide Vaccine (23-Valent)-Laryng-O-Jet
- Pneumococcal Polysaccharide Vaccine (23-Valent)-Laryngesic